239 related articles for article (PubMed ID: 21666157)
21. Two-dose measles vaccination schedules.
Rosenthal SR; Clements CJ
Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
[TBL] [Abstract][Full Text] [Related]
22. Progress Toward Measles Elimination - African Region, 2013-2016.
Masresha BG; Dixon MG; Kriss JL; Katsande R; Shibeshi ME; Luce R; Fall A; Dosseh ARGA; Byabamazima CR; Dabbagh AJ; Goodson JL; Mihigo R
MMWR Morb Mortal Wkly Rep; 2017 May; 66(17):436-443. PubMed ID: 28472026
[TBL] [Abstract][Full Text] [Related]
23. Progress toward measles elimination--European Region, 2005--2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
[TBL] [Abstract][Full Text] [Related]
24. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
Khanal S; Kassem AM; Bahl S; Jayantha L; Sangal L; Sharfuzzaman M; Bose AS; Antoni S; Datta D; Alexander JP
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1042-1046. PubMed ID: 35980874
[TBL] [Abstract][Full Text] [Related]
25. Progress Toward Measles Elimination - Western Pacific Region, 2013-2017.
Hagan JE; Kriss JL; Takashima Y; Mariano KML; Pastore R; Grabovac V; Dabbagh AJ; Goodson JL
MMWR Morb Mortal Wkly Rep; 2018 May; 67(17):491-495. PubMed ID: 29723171
[TBL] [Abstract][Full Text] [Related]
26. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
27. Experience in global measles control, 1990-2001.
Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
[TBL] [Abstract][Full Text] [Related]
28. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
[TBL] [Abstract][Full Text] [Related]
29. Progress toward measles elimination--Japan, 1999-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
[TBL] [Abstract][Full Text] [Related]
30. Do income inequality and social capital associate with measles-containing vaccine coverage rate?
Nagaoka K; Fujiwara T; Ito J
Vaccine; 2012 Dec; 30(52):7481-8. PubMed ID: 23107596
[TBL] [Abstract][Full Text] [Related]
31. Progress toward measles elimination in the People's Republic of China, 2000-2009.
Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
[TBL] [Abstract][Full Text] [Related]
32. Accelerated measles control--Cambodia, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
[TBL] [Abstract][Full Text] [Related]
33. Maintaining high rates of measles immunization in Africa.
Lessler J; Moss WJ; Lowther SA; Cummings DA
Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
[TBL] [Abstract][Full Text] [Related]
34. Progress in measles control--Nepal, 2000-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(39):1028-31. PubMed ID: 17914331
[TBL] [Abstract][Full Text] [Related]
35. Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.
Zuo S; Cairns L; Hutin Y; Liang X; Tong Y; Zhu Q; Zhang D; Lee LA; Strebel P; Quick L
Vaccine; 2015 Apr; 33(17):2050-5. PubMed ID: 25769207
[TBL] [Abstract][Full Text] [Related]
36. Progress in measles and rubella elimination in Iran.
Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
[TBL] [Abstract][Full Text] [Related]
37. Supplementary immunization activities to achieve measles elimination: experience of the European Region.
Khetsuriani N; Deshevoi S; Goel A; Spika J; Martin R; Emiroglu N
J Infect Dis; 2011 Jul; 204 Suppl 1():S343-52. PubMed ID: 21666183
[TBL] [Abstract][Full Text] [Related]
38. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
[TBL] [Abstract][Full Text] [Related]
39. Progress toward measles elimination—Philippines, 1998-2014.
Takashima Y; Schluter WW; Mariano KM; Diorditsa S; de Quiroz Castro M; Ou AC; Ducusin MJ; Garcia LC; Elfa DC; Dabbagh A; Rota P; Goodson JL;
MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):357-62. PubMed ID: 25856257
[TBL] [Abstract][Full Text] [Related]
40. Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy.
Kumar SS; Hartner AM; Chandran A; Gaythorpe KAM; Li X
BMC Public Health; 2023 Nov; 23(1):2351. PubMed ID: 38017415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
